Menu
Sign In Pricing Add Podcast
Podcast Image

Wall Street Breakfast

CVS pulls phenylephrine amid legal woes

Fri, 20 Oct 2023

Description

Drug retailers, makers face mounting litigation over decongestant products. (00:25) Toyota (TM) works out deal with Tesla (TSLA) to adopt NACS charging standard. (02:27) Jazz Pharmaceuticals (JAZZ) exploring strategic options, including sale - Bloomberg. (03:15)Episode transcripts seekingalpha.com/wsb.Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.Show links: Biggest stock movers today: SolarEdge Technologies, Intuitive Surgical and moreChina to restrict exports of key EV battery material graphiteMicrosoft paid top boss Nadella $48.5M in fiscal 2023Starbucks sues Workers United union over damaging social media postMarket investors aren’t as worried about the state of the world as they should be - Paul Singer

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

No transcription available yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.